Confirmatory Results

Differential outcomes of infection by wild-type SARS-CoV-2 and the B.1.617.2 and B.1.1.529 variants of concern in K18-hACE2 transgenic mice

Yicheng He, Jill Henley, Philip Sell, Lucio Comai
doi: https://doi.org/10.1101/2023.09.08.556906

Article Information

doi 
https://doi.org/10.1101/2023.09.08.556906
History 
  • December 14, 2023.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Yicheng He1,*,
  2. Jill Henley2,
  3. Philip Sell1,2 and
  4. Lucio Comai1,2,*
  1. 1Department of Molecular Microbiology and Immunology
  2. 2Hastings Foundation and Wright Foundation BSL3 laboratory, Keck School of Medicine, University of Southern California, Los Angeles, CA 90089
  1. ↵*Correspondence: heyichen{at}usc.edu;comai{at}med.usc.edu
Back to top
Posted December 14, 2023.
Download PDF

Supplementary Material

Email
Differential outcomes of infection by wild-type SARS-CoV-2 and the B.1.617.2 and B.1.1.529 variants of concern in K18-hACE2 transgenic mice
Yicheng He, Jill Henley, Philip Sell, Lucio Comai
bioRxiv 2023.09.08.556906; doi: https://doi.org/10.1101/2023.09.08.556906
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area